Our analysis revealed tumor-infiltrating CD8+ T-cells, particularly CD8+ effector memory T-cells, were mainly enriched in MPM harboring LATS1/2 mutation, compared with NF2-mutant MPM and other cancer types (Figure 4A). The gene discussed is CD8A; the disease is cancer.